Molnupiravir, the US-made drug intended for Covid-19 treatment and marketed in some regions as Molnatris, will be sold at private hospitals, clinics and pharmacies to the public from December 23 onwards. Healthcare businesses wishing to distribute the drug can buy it from the Ministry of Post and Telecommunications during working hours from Monday to Friday.